Capstone Investment Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $234K | Sell |
2,591
-2,220
| -46% | -$204K | ﹤0.01% | 1474 |
|
|
2025
Q4 | $433K | Buy |
+4,811
| New | +$456K | ﹤0.01% | 1198 |
|
|
2025
Q3 | – | Sell |
-3,635
| Closed | -$360K | – | 2110 |
|
|
2025
Q2 | $332K | Buy |
+3,635
| New | +$351K | ﹤0.01% | 1345 |
|
|
2025
Q1 | – | Sell |
-10,400
| Closed | -$1.11M | – | 1942 |
|
|
2024
Q4 | $1.1M | Buy |
10,400
+3,987
| +62% | +$428K | ﹤0.01% | 1037 |
|
|
2024
Q3 | $692K | Sell |
6,413
-4,067
| -39% | -$444K | ﹤0.01% | 1102 |
|
|
2024
Q2 | $1.14M | Buy |
10,480
+6,617
| +171% | +$780K | ﹤0.01% | 934 |
|
|
2024
Q1 | $510K | Buy |
3,863
+3,783
| +4,729% | +$473K | ﹤0.01% | 1546 |
|
|
2023
Q4 | $9.74K | Sell |
80
-2,094
| -96% | -$234K | ﹤0.01% | 2059 |
|
|
2023
Q3 | $244K | Buy |
2,174
+1,438
| +195% | +$183K | ﹤0.01% | 1712 |
|
|
2023
Q2 | $107K | Buy |
736
+633
| +615% | +$86K | ﹤0.01% | 1687 |
|
|
2023
Q1 | $13.3K | Buy |
+103
| New | +$12.9K | ﹤0.01% | 1472 |
|
|
2022
Q4 | – | Sell |
-13,109
| Closed | -$1.37M | – | 1684 |
|
|
2022
Q3 | $1.37M | Buy |
13,109
+10,317
| +370% | +$1.13M | 0.01% | 909 |
|
|
2022
Q2 | $293K | Buy |
2,792
+2,791
| +279,100% | +$331K | ﹤0.01% | 1352 |
|
|
2022
Q1 | $0 | Sell |
1
-40,967
| -100% | -$4.94M | ﹤0.01% | 2180 |
|
|
2021
Q4 | $5.05M | Buy |
40,968
+21,746
| +113% | +$2.85M | 0.01% | 821 |
|
|
2021
Q3 | $2.73M | Buy |
19,222
+13,599
| +242% | +$2M | 0.01% | 1091 |
|
|
2021
Q2 | $878K | Buy |
+5,623
| New | +$911K | ﹤0.01% | 1267 |
|
|
2021
Q1 | – | Sell |
-122
| Closed | -$18.9K | – | 1974 |
|
|
2020
Q4 | $18K | Buy |
+122
| New | +$17.2K | ﹤0.01% | 1646 |
|
|
2017
Q4 | – | Sell |
-5,760
| Closed | -$654K | – | 688 |
|
|
2017
Q3 | $654K | Buy |
+5,760
| New | +$665K | 0.02% | 277 |
|
|
2016
Q4 | – | Sell |
-2,163
| Closed | -$273K | – | 1140 |
|
|
2016
Q3 | $273K | Sell |
2,163
-515
| -19% | -$63.6K | 0.01% | 629 |
|
|
2016
Q2 | $312K | Buy |
+2,678
| New | +$303K | 0.01% | 556 |
|
|
2016
Q1 | – | Sell |
-2,369
| Closed | -$235K | – | 788 |
|
|
2015
Q4 | $235K | Buy |
+2,369
| New | +$232K | 0.01% | 415 |
|
|
2014
Q4 | – | Sell |
-10,300
| Closed | -$1M | – | 435 |
|
|
2014
Q3 | $1M | Buy |
10,300
+2,678
| +35% | +$263K | 0.01% | 338 |
|
|
2014
Q2 | $768K | Buy |
+7,622
| New | +$744K | 0.01% | 332 |
|
Other funds holding ZBH
VCM
VPM
Capstone Investment Advisors's ZBH Position: Q1 2026 in Review
Capstone Investment Advisors reduced its Zimmer Biomet (ZBH) stake by 46% in Q1 2026, selling an estimated $204K and leaving 2,591 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.
Capstone Investment Advisors first reported a position in ZBH in Q2 2014 and has held it in 24 quarters since. The position peaked at $5.05M in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Capstone Investment Advisors held 2,591 shares of Zimmer Biomet worth $234K as of Q1 2026.
- Capstone Investment Advisors sold 2,220 Zimmer Biomet shares in Q1 2026, an estimated $204K.
- Zimmer Biomet made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1474 holding.
- Capstone Investment Advisors first reported a position in Zimmer Biomet in Q2 2014 and has held it in 24 quarters since.
- Capstone Investment Advisors's Zimmer Biomet position peaked at $5.05M in Q4 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.